Tachi Yamada's guest appearances

Tachi Yamada

Gut Talk

Peter Gibson

Barry Marshall

Brennan Spiegel

David Greenwald

H. Pylori

Gil Y. Melmed

Douglas Drossman

Austin Chiang

Mark Pochapin

Sophie M

Lin Chang

OwlTail

In this episode, we spoke with one of the luminaries of gastroenterology, Tachi Yamada, MD, about the guiding principles that led him through his GI career, the art of embracing change and what he learned about global health from working at the Gates Foundation.     Intro :10 About Dr. Yamada :14 The interview 4:48 Are there experiences from early in your life that you pull from today? 5:18 How did you end up doing basic science research? 8:50 How were you recruited to Michigan? 15:25 Do you have any advice for choosing mentors? 19:45 How did you decide to go to GSK as head of R&amp;D? 26:28 Were there any cultural differences when you made the switch to industry? 29:47 What about the transition into philanthropy? 35:23 Have you gained insights that might provide wisdom amid COVID-19? 42:39 Are there open channels of communication that will help facilitate best practices? 49:54 What advice do you have for early career physicians? 52:16 Thanks for listening 55:00  Tachi Yamada, MD, is chief medical officer,Takeda Pharmaceuticals; former chief of GI, University of Michigan; and former president, AGA. We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc Disclosures: Berry and Chey report no relevant financial disclosures. Yamada reports he owns stock in Agilent, Arcutis, CSL, Keysight, Passage and Phathom. References: Yamada T, Ogawa VA, Freire M. Nature. 2016;533:29-31.

In this episode, we spoke with one of the luminaries of gastroenterology, Tachi Yamada, MD, about the guiding principles that led him through his GI career, the art of embracing change and what he learned about global health from working at the Gates Foundation.    <ul> <li>Intro :10</li> <li>About Dr. Yamada :14</li> <li>The interview 4:48</li> <li>Are there experiences from early in your life that you pull from today? 5:18</li> <li>How did you end up doing basic science research? 8:50</li> <li>How were you recruited to Michigan? 15:25</li> <li>Do you have any advice for choosing mentors? 19:45</li> <li>How did you decide to go to GSK as head of R&amp;D? 26:28</li> <li>Were there any cultural differences when you made the switch to industry? 29:47</li> <li>What about the transition into philanthropy? 35:23</li> <li>Have you gained insights that might provide wisdom amid COVID-19? 42:39</li> <li>Are there open channels of communication that will help facilitate best practices? 49:54</li> <li>What advice do you have for early career physicians? 52:16</li> <li>Thanks for listening 55:00</li> </ul> Tachi Yamada, MD, is chief medical officer,Takeda Pharmaceuticals; former chief of GI, University of Michigan; and former president, AGA. We’d love to hear from you! Send your comments/questions to <a href="mailto:guttalkpodcast@healio.com">guttalkpodcast@healio.com</a>. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc Disclosures: Berry and Chey report no relevant financial disclosures. Yamada reports he owns stock in Agilent, Arcutis, CSL, Keysight, Passage and Phathom. References: <a href="https://www.nature.com/articles/533029a.pdf?origin=ppub" rel="noopener nofollow" target="_blank">Yamada T, Ogawa VA, Freire M. Nature. 2016;533:29-31.</a>

Tachi Yamada, MD: Non-traditional Careers in Medicine